Paragon Bioservice’s CEO, Pete Buzy shares The Buzz About Leadership on MTC’s New Podcast
May 29, 2019
Paragon has become one of Maryland’s big success stories.
The Maryland-based company’s story begins in 1990 with Founder, Marco Chacon, PhD. They started in a local JHU incubator where they strategically leveraged the resources of the University of Maryland Scale-Up Facility to extend their production capacity to meet customer needs and expand in their early days. Later they became a core tenant of the UM BioPark and attracted capital investment from a syndicate that included local private equity firm, Camden Partners in 2014 which fueled their growth to over 150 employees. In 2018 they began expansion with a state of the art cGMP Gene Therapy Manufacturing Facility near BWI that was completed in 2019. Just day’s after the grand opening of that new facility they announced their acquisition by global CDMO Catalent for $1.2B.
Pete Buzy joined Paragon in 2014 and helped Chacon with the company’s first capital raise, including the Camden Partners investment. and became President and CEO in September 2016. Bringing with him over 25 years of successful executive management experience, Pete has grown the company into a premier CDMO with a leading position in gene therapy and next-generation vaccines. With expertise in growing companies and increasing their value, Buzy recruited and attracted a top tier leadership team and was instrumental in leading the company to successfully achieve double-digit growth and the blockbuster acquisition by Catalent.
Talk about a journey of value creation, scale, success and leadership.
Buzy recently joined Marty Rosendale is CEO of MTC as a guest on “Capital M”, a Podcast Addressing Capital Markets in Maryland and the Mid-Atlantic. With a resume like his, Buzy proved to be an ideal guest, providing some great insight into the fascinating Paragon story and his career in navigating the growth and sale of multiple life science companies.
About Capital M:
Raising equity capital has been described as one of the biggest challenges for early and mid-stage companies in the Mid-Atlantic. With the launch of the Capital M podcast, the Maryland Tech Council (MTC) hopes to address capital markets in this region and elevate the conversation to help companies prepare for the market. Marty Rosendale, CEO of MTC and host of the podcast, sits down with top executives who have successfully raised capital to discuss access to capital, what it means to be ready for the capital markets in this region, and their strategy for engaging with Venture Capital investors and Private Equity firms. Join the conversation!
Latest posts by Chris Frew (see all)
- Gyroscope Therapeutics, which has operations in King of Prussia, raises $148M - March 31, 2021
- TCR² Therapeutics Acquires Cell Therapy Manufacturing Facility & New VP of Technical Operations, Aaron Vernon - March 29, 2021
- Frederick Based Biotech Law Firm McBee Moore & Vanik IP, LLC Celebrates Five Years - February 18, 2021
- Heather Mudrick Joins Workforce Genetics to Lead Clinical Search Practice - February 12, 2021
- RNA Disease Diagnostics, Inc. Takes Exclusive License to Cutting-Edge Molecular RNA Diagnostic Platform Technology from UMB and UMBC - February 4, 2021